Literature DB >> 1953411

Psychiatric effects of selegiline.

S J Boyson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1953411     DOI： 10.1001/archneur.1991.00530210028017

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  4 in total

1.  A case of glioblastoma masquerading as an affective disorder.

Authors:  Albino J Oliveira-Maia; Joana Ruivo; J Bernardo Barahona-Corrêa
Journal:  Prim Care Companion CNS Disord       Date:  2014-12-25

Review 2.  Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment.

Authors:  B K Young; R Camicioli; L Ganzini
Journal:  Drugs Aging       Date:  1997-05       Impact factor: 3.923

Review 3.  Comparative tolerability profiles of the newer versus older antidepressants.

Authors:  M V Rudorfer; H K Manji; W Z Potter
Journal:  Drug Saf       Date:  1994-01       Impact factor: 5.606

Review 4.  Safety of selegiline (deprenyl) in the treatment of Parkinson's disease.

Authors:  E H Heinonen; V Myllylä
Journal:  Drug Saf       Date:  1998-07       Impact factor: 5.606
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.